Kara Dwight, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Rr 1 Box 11, Machias, ME 04654 Phone: 207-255-3356 Fax: 207-255-0289 |
News Archive
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute and breakthrough pain, today announced the initiation of an open-label Phase 3 study (SAP302) of ARX-04 for the treatment of adult patients who present in the emergency room with moderate-to-severe acute pain associated with trauma or injury.
Delivering drugs to the brain is no easy task. The blood-brain barrier -a protective sheath of tissue that shields the brain from harmful chemicals and invaders - cannot be penetrated by most therapeutics that are injected into a person's blood stream.
According to experts over 24 million people worldwide are thought to suffer from dementia, and many of these people live in low and middle-income countries.
Although there have been questions regarding the safety and durability of endoscopic vein graft harvest for coronary artery bypass graft (CABG) surgery, an analysis of data of more than 200,000 patients who underwent CABG surgery found no evidence of a long-term increased risk of death with endoscopic vein graft harvesting compared to open vein-graft harvesting, according to a study in the August 1 issue of JAMA.
› Verified 7 days ago